Calcium-sensing receptor autoantibodies in primary hyperparathyroidism

Clinica Chimica Acta

Volumn 406, Issue 1-2, 2009, Pages 94-97

  Charrié, Anne ^a,b   Chikh, Karim ^a,b,c,d   Peix, Jean Louis ^b   Berger, Nicole ^e   Decaussin, Myriam ^e   Veber, Sophie ^e   Bienvenu, Jacques ^a,c,e   Lifante, Jean Christophe ^b   Fabien, Nicole ^a,c,e  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ CLAUDE BERNARD LYON 1   (France)

^c INSERM   (France)

^d UNIVERSITÉ LYON 1   (France)

^e CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Autoantibodies; Calcium sensing receptor; Hyperparathyroidism

Indexed keywords

AUTOANTIBODY; CALCIUM SENSING RECEPTOR; PARATHYROID HORMONE;

ADULT; AGED; ANTIBODY TITER; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PARATHYROID ADENOMA; PARATHYROID GLAND; PATHOPHYSIOLOGY; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PROTEIN DOMAIN; THYROID SURGERY;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CALCIUM; COHORT STUDIES; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; PARATHYROID HORMONE; RECEPTORS, CALCIUM-SENSING;

EID: 67650248241     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.05.023     Document Type: Article

References (26)

1. Brown E.M., Gamba G., Riccardi D., et al. Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 366 (1993) 575-580
2. Pearce S.H., Trump D., Wooding C., et al. Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J Clin Invest 96 (1995) 2683-2692
3. Hendy G.N., D Souza-Li L., Yang B., et al. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat 16 (2000) 281-296
4. Pollak M.R., Brown E.M., Chou Y.H., et al. Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75 (1993) 1297-1303
5. Chou Y.H., Pollak M.R., Brandi M.L., et al. Mutations in the human Ca(2+)-sensing-receptor gene that cause familial hypocalciuric hypercalcemia. Am J Hum Genet 56 (1995) 1075-1079
6. Pollak M.R., Brown E.M., Estep H.L., et al. Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation. Nat Genet 8 (1994) 303-307
7. Lienhardt A., Bai M., Lagarde J.P., et al. Activating mutations of the calcium-sensing receptor: management of hypocalcemia. J Clin Endocrinol Metab 86 (2001) 5313-5323
8. Heath III H., Jackson C.E., Otterud B., et al. Genetic linkage analysis in familial benign (hypocalciuric) hypercalcemia: evidence for locus heterogeneity. Am J Hum Genet 53 (1993) 193-200
9. Hosokawa Y., Pollak M.R., Brown E.M., et al. Mutational analysis of the extracellular Ca(2+)-sensing receptor gene in human parathyroid tumors. J Clin Endocrinol Metab 80 (1995) 3107-3110
10. Kifor O., Moore Jr. F.D., Delaney M., et al. A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor. J Clin Endocrinol Metab 88 (2003) 60-72
11. Li Y., Song Y.H., Rais N., et al. Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. J Clin Invest 97 (1996) 910-914
12. Mayer A., Ploix C., Orgiazzi J., et al. Calcium-sensing receptor autoantibodies are relevant markers of acquired hypoparathyroidism. J Clin Endocrinol Metab 89 (2004) 4484-4488
13. Gavalas N.G., Kemp E.H., Krohn K.J., et al. The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab 92 (2007) 2107-2114
14. Bjerneroth G., Juhlin C., Gudmundsson S., et al. Major histocompatibility complex class II expression and parathyroid autoantibodies in primary hyperparathyroidism. Surgery 124 (1998) 503-509
15. Fabien N., Moreira A., Lavergne J.P., et al. Autoantibodies directed against the ribosomal P proteins are not only directed against a common epitope of the P0, P1 and P2 proteins. J Autoimmun 13 (1999) 103-110
16. Ferraro-Peyret C., Coury F., Tebib J.G., et al. Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective study. Arthritis Res Ther 6 (2004) R535-R543
17. Pallais J.C., Kifor O., Chen Y.B., et al. Acquired hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor. N Engl J Med 351 (2004) 362-369
18. Makita N., Sato J., Manaka K., et al. An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations. Proc Natl Acad Sci U S A 104 (2007) 5443-5448
19. Peix J.L., el Khazen M., Mancini F., et al. [Surgery for primary hyperparathyroidism in 1998. Apropos of 66 patients and 3 methods of approach]. Ann Chir 125 (2000) 346-352
20. Kifor O., Moore Jr. F.D., Wang P., et al. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 81 (1996) 1598-1606
21. Yano S., Sugimoto T., Tsukamoto T., et al. Decrease in vitamin D receptor and calcium-sensing receptor in highly proliferative parathyroid adenomas. Eur J Endocrinol 148 (2003) 403-411
22. Veress B., and Nordenstrom J. Lymphocytic infiltration and destruction of parathyroid adenomas: a possible tumour-specific autoimmune reaction in two cases of primary hyperparathyroidism. Histopathology 25 (1994) 373-377
23. Tfelt-Hansen J., and Brown E.M. The calcium-sensing receptor in normal physiology and pathophysiology: a review. Crit Rev Clin Lab Sci 42 (2005) 35-70
24. Pelletier-Morel L., Fabien N., Mouhoub Y., et al. Hyperparathyroidism in a patient with autoimmune polyglandular syndrome. Intern Med 47 (2008) 1911-1915
25. Ando T, Latif R, Davies TF. Thyrotropin receptor antibodies: new insights into their actions and clinical relevance. Best Pract Res Clin Endocrinol Metab 2005;19:33--52.
26. Orgiazzi J. Anti-TSH receptor antibodies in clinical practice. Endocrinol Metab Clin North Am 29 (2000) 339-355 vii